ViaLongeVita

This article was automatically translated into your selected language.(mymemory)

抗真菌療法は、炎症性腸疾患における微生物のダイナミクスを改善します。VIP

Nature Medicine, Published online: 01 September 2026; doi:10.1038/s41591-026-04616-y In an prospective observational study of patients with inflammatory bowel disease with oral thrush, the treatment of fluconazole (orogastrointestinal therapy), but not nystatin (oral therapy), led to intestinal mycobiome and microbiome

このコンテンツは医学的診断や治療の推奨ではありません。必ず医師にご相談ください。

Illustration for "抗真菌療法は、炎症性腸疾患における微生物のダイナミクスを改善します。" — current health topic, diverse group of adults

Enjoying this article? Support the editorial team with a tip

Nature Medicine, Published online: 01 September 2026; doi:10.1038/s41591-026-04616-y In an prospective observational study of patients with inflammatory bowel disease with oral thrush, the treatment of fluconazole (orogastrointestinal therapy), but not nystatin (oral therapy), led to intestinal mycobiome and microbiome

Pro váš zájem

Tento obsah je součástí MedScope VIP

Na základě vašeho zájmu o medicínu jsme pro vás připravili plný přístup k odborným článkům, alertům a AI asistentovi.

14 dní zkušební verze zdarma — vyzkoušejte bez rizika

Odemknout předplatným

Již máte účet? Přihlásit se · Srovnání tarifů

Support the author (MedScopeGlobal Editorial) · Tip

Optional micro-contribution — like a tip. Funds ViaLongeVita editorial.

A tip is not a VIP subscription and does not unlock paid content — it is optional support for the desk.

Contribution

Donate

A micro-donation helps us keep publishing quality content.

Related reading

Recommended content

Prepared by the MedScopeGlobal.com editorial team — educational health content for the public. Always consult a physician for personal medical decisions.